Columbia Sportswear Company (COLM) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
4 Feb, 2026Executive summary
Q4 2025 net sales declined 2% year-over-year to $1,070M, mainly due to U.S. weakness, while full-year net sales increased 1% to $3.4 billion, with international growth offsetting U.S. headwinds.
Gross margin expanded 50 bps to 51.6% in Q4, driven by healthier inventory and less clearance activity, despite $20M in incremental U.S. tariffs.
Operating income and diluted EPS declined year-over-year, with Q4 operating income down 15% to $116.7M and diluted EPS at $1.73, impacted by $29M in impairment charges.
The Columbia Accelerate Growth Strategy, new product launches, and marketing campaigns like "Engineered for Whatever" are resonating with younger consumers and driving brand momentum.
Ended 2025 with $791 million in cash and no debt.
Financial highlights
Full year 2025 net sales rose 1% to $3,397M, with gross margin up 30 bps to 50.5% and operating margin down 190 bps to 6.1%.
Q4 net sales were $1.1 billion, with a 7% decline in wholesale partially offset by a 1% increase in DTC sales.
SG&A expenses increased 3% in Q4, mainly from higher DTC and non-recurring profit improvement program costs.
Free cash flow for 2025 was $217M, down from $431M in 2024.
Share repurchases totaled $201M and quarterly dividend declared at $0.30/share.
Outlook and guidance
2026 net sales expected to grow 1–3% to $3.43–$3.50 billion, with a slight FX tailwind.
Operating margin projected at 6.2–6.9%, with diluted EPS of $3.20–$3.65, including a $0.10 FX benefit.
Gross margin expected to contract to 49.8–50.0% due to incremental tariffs, with mitigation efforts underway.
Q1 2026 sales anticipated to decline 2.5–4%, with EPS of $0.29–$0.37.
U.S. wholesale expected to return to growth in the second half of 2026; international growth to outpace U.S.
Latest events from Columbia Sportswear Company
- Flat Q1 sales, improved FY2026 outlook, and strong international growth offset U.S. softness.COLM
Q1 20267 May 2026 - 2025 delivered modest sales growth, strong global expansion, and robust financial discipline.COLM
Investor presentation30 Apr 2026 - 2026 annual meeting covers director elections, pay, stock plan, and proxy access, with Board opposition to proxy access.COLM
Proxy filing24 Apr 2026 - Key votes include board elections, auditor ratification, and a proxy access proposal.COLM
Proxy filing24 Apr 2026 - Q2 sales fell 8% with a net loss, but strong cash and inventory cuts support a steady outlook.COLM
Q2 20242 Feb 2026 - Q3 sales fell 5% as North America lagged, but gross margin rose and EPS guidance increased.COLM
Q3 202417 Jan 2026 - 2025 outlook targets modest growth, margin gains, and brand investment, led by EMEA and LAAP.COLM
Q4 20248 Jan 2026 - Q1 sales up 1%, margin gains, but outlook withdrawn amid tariff and macro uncertainty.COLM
Q1 20256 Jan 2026 - Board recommends all director nominees, auditor ratification, and opposes new GHG targets.COLM
Proxy Filing1 Dec 2025